BG61493B2 - Пуринови производни и фармацевтичната им употреба - Google Patents

Пуринови производни и фармацевтичната им употреба Download PDF

Info

Publication number
BG61493B2
BG61493B2 BG098209A BG9820993A BG61493B2 BG 61493 B2 BG61493 B2 BG 61493B2 BG 098209 A BG098209 A BG 098209A BG 9820993 A BG9820993 A BG 9820993A BG 61493 B2 BG61493 B2 BG 61493B2
Authority
BG
Bulgaria
Prior art keywords
formula
compound
purine
amino
group
Prior art date
Application number
BG098209A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michael Harnden
Richard Jarvest
Original Assignee
Novartis International Pharmaceutical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848423833A external-priority patent/GB8423833D0/en
Priority claimed from GB858510331A external-priority patent/GB8510331D0/en
Priority claimed from GB858520618A external-priority patent/GB8520618D0/en
Application filed by Novartis International Pharmaceutical Ltd. filed Critical Novartis International Pharmaceutical Ltd.
Publication of BG61493B2 publication Critical patent/BG61493B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG098209A 1984-09-20 1993-11-10 Пуринови производни и фармацевтичната им употреба BG61493B2 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848423833A GB8423833D0 (en) 1984-09-20 1984-09-20 Compounds
GB858510331A GB8510331D0 (en) 1985-04-23 1985-04-23 Compounds
GB858520618A GB8520618D0 (en) 1985-08-16 1985-08-16 Compounds

Publications (1)

Publication Number Publication Date
BG61493B2 true BG61493B2 (bg) 1997-09-30

Family

ID=27262464

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098209A BG61493B2 (bg) 1984-09-20 1993-11-10 Пуринови производни и фармацевтичната им употреба

Country Status (24)

Country Link
EP (1) EP0182024B1 (en, 2012)
JP (2) JPS6185388A (en, 2012)
KR (1) KR930006349B1 (en, 2012)
AT (1) AT389118B (en, 2012)
AU (1) AU589371B2 (en, 2012)
BG (1) BG61493B2 (en, 2012)
CA (1) CA1262899A (en, 2012)
CY (1) CY1747A (en, 2012)
CZ (1) CZ283721B6 (en, 2012)
DE (1) DE3582399D1 (en, 2012)
DK (1) DK167019B1 (en, 2012)
ES (1) ES8703876A1 (en, 2012)
FI (1) FI87564C (en, 2012)
GR (1) GR852272B (en, 2012)
HK (1) HK128693A (en, 2012)
HU (1) HU198934B (en, 2012)
IE (1) IE58141B1 (en, 2012)
MX (1) MX165116B (en, 2012)
MY (1) MY102473A (en, 2012)
NL (1) NL960006I1 (en, 2012)
NO (1) NO167572C (en, 2012)
NZ (1) NZ213528A (en, 2012)
PT (1) PT81160B (en, 2012)
WO (1) WO1987005604A1 (en, 2012)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
ES2098219T3 (es) * 1987-08-01 1997-05-01 Beecham Group Plc Compuestos de purina y su preparacion.
US5175288A (en) * 1987-08-01 1992-12-29 Beecham Group P.L.C. Process for preparing purine derivatives and intermediates thereof
GB8817270D0 (en) * 1988-07-20 1988-08-24 Beecham Group Plc Novel process
GB8817607D0 (en) * 1988-07-23 1988-09-01 Beecham Group Plc Novel process
GB8822236D0 (en) * 1988-09-21 1988-10-26 Beecham Group Plc Chemical process
CA2009109A1 (en) * 1989-02-02 1990-08-02 John Hannah Antiviral acyclonucleosides and acyclonucleotides
JPH02247191A (ja) * 1989-02-02 1990-10-02 Merck & Co Inc 抗レトロウイルス剤としてのプリンおよびピリミジン非環状ヌクレオシドの環状モノホスフエート類
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
GB8922076D0 (en) * 1989-09-28 1989-11-15 Beecham Group Plc Novel process
GB9004647D0 (en) * 1990-03-01 1990-04-25 Beecham Group Plc Pharmaceuticals
GB9102127D0 (en) * 1991-01-31 1991-03-13 Smithkline Beecham Plc Pharmaceuticals
GB9201961D0 (en) 1992-01-30 1992-03-18 Smithkline Beecham Plc Pharmaceuticals
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9323403D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
US6683084B1 (en) 1993-11-12 2004-01-27 Novartis International Pharmaceutical Ltd. Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
GB9407698D0 (en) 1994-04-19 1994-06-15 Smithkline Beecham Plc Pharmaceuticals
DE4420751A1 (de) * 1994-06-15 1995-12-21 Basf Ag Verfahren zur Herstellung von enantiomerenreinen Lactamen
AU695032B2 (en) * 1994-10-05 1998-08-06 Darwin Discovery Limited Purine and guanine compounds as inhibitors of PNP
RU2181049C2 (ru) * 1994-12-12 2002-04-10 Новартис Интернэшнл Фармасьютикал Лтд. Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
GB9504497D0 (en) * 1995-03-07 1995-04-26 Smithkline Beecham Plc Pharmaceuticals
GB9600847D0 (en) 1996-01-16 1996-03-20 Smithkline Beecham Plc Pharmaceuticals
US7279483B2 (en) 1996-02-07 2007-10-09 Novartis Ag Famciclovir monohydrate
DE69706833T2 (de) * 1996-02-07 2002-04-11 Novartis International Pharmaceutical Ltd., Hamilton Pharmazeutische zusammensetzungen enthaltend famciclovir monohydrat
AT412211B (de) * 1996-07-20 2004-11-25 Novartis Int Pharm Ltd Verfahren zur herstellung von penciclovir und famciclovir
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
CA2251481A1 (en) 1997-11-12 1999-05-12 Junichi Yasuoka Purine derivatives having cyclopropane ring
GB9807116D0 (en) * 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
SI20022A (sl) * 1998-07-29 2000-02-29 Kemijski inštitut Alkilno substituirani purinovi derivati in njihova priprava
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US20040097528A1 (en) 2002-08-26 2004-05-20 Ben-Zion Dolitzky Crystalline solid famciclovir forms I, II, III and preparation thereof
US20060234982A1 (en) 2003-01-14 2006-10-19 Dahl Terrence C Compositions and methods for combination antiviral therapy
AU2006230269A1 (en) 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
GB2426247A (en) * 2005-05-20 2006-11-22 Arrow Int Ltd Methods of preparing purine derivatives such as famciclovir
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition
CA3007063A1 (en) * 2015-12-08 2017-06-15 Retrophin, Inc. Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3376325D1 (en) * 1982-10-14 1988-05-26 Wellcome Found Antiviral purine derivatives
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
AU577303B2 (en) * 1983-08-18 1988-09-22 Novartis International Pharmaceutical Ltd 9-substituted-2-amino purines
EP0152316B1 (en) * 1984-01-26 1989-07-26 Merck & Co. Inc. Substituted butyl guanines and their utilization in antiviral compositions

Also Published As

Publication number Publication date
CA1262899A (en) 1989-11-14
FI875059A0 (fi) 1987-11-16
NO874764D0 (no) 1987-11-16
IE58141B1 (en) 1993-07-14
AU4756085A (en) 1986-03-27
FI87564B (fi) 1992-10-15
HU198934B (en) 1989-12-28
MY102473A (en) 1992-06-30
KR930006349B1 (ko) 1993-07-14
NO874764L (no) 1987-11-16
PT81160B (pt) 1988-01-22
GR852272B (en, 2012) 1986-01-21
CS391591A3 (en) 1992-05-13
AT389118B (de) 1989-10-25
NZ213528A (en) 1989-03-29
JPH0826021B2 (ja) 1996-03-13
DE3582399D1 (de) 1991-05-08
FI87564C (fi) 1993-01-25
DK424685D0 (da) 1985-09-18
JPS6185388A (ja) 1986-04-30
NO167572C (no) 1991-11-20
WO1987005604A1 (en) 1987-09-24
DK167019B1 (da) 1993-08-16
JPH0625241A (ja) 1994-02-01
ATA904286A (de) 1989-03-15
NL960006I2 (nl) 1996-09-02
HUT47576A (en) 1989-03-28
CY1747A (en) 1994-06-03
JPH0586792B2 (en, 2012) 1993-12-14
ES547128A0 (es) 1987-03-01
HK128693A (en) 1993-11-26
EP0182024B1 (en) 1991-04-03
EP0182024A3 (en) 1989-03-08
IE852307L (en) 1986-03-20
AU589371B2 (en) 1989-10-12
FI875059L (fi) 1987-11-16
NL960006I1 (nl) 1996-09-02
EP0182024A2 (en) 1986-05-28
CZ283721B6 (cs) 1998-06-17
MX165116B (es) 1992-10-27
NO167572B (no) 1991-08-12
ES8703876A1 (es) 1987-03-01
DK424685A (da) 1986-03-21
PT81160A (en) 1985-10-01

Similar Documents

Publication Publication Date Title
BG61493B2 (bg) Пуринови производни и фармацевтичната им употреба
JP2543822B2 (ja) グアニン誘導体
US5246937A (en) Purine derivatives
US4495190A (en) Derivatives of guanine for combating herpes virus infections
FI93546C (fi) Menetelmä terapeuttisesti käyttökelpoisten dideoksikarbosyklisten nukleosidianalogien valmistamiseksi
CA1276635C (en) 9-(2-(hydroxymethyl)cycloalkylmethyl)guanines
US5342840A (en) Cyclopropane derivative
EP0138656B1 (en) Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions
HU200461B (en) Process for producing new 9-(n-hyudroxyalkoxy)-purine derivatives and pharmaceutical compositions comprising such compounds
IE914171A1 (en) Pharmaceuticals
EP0173624A2 (en) 4-(guanin-9-yl) butanals and antiviral compositions containing them
AU3760793A (en) Antiviral phosphonic acid derivatives of purine analogues
US4845084A (en) Phosphate derivatives of substituted butyl guanines, antiviral compositions containing them, and methods of treating viral infections with them
EP0130126A1 (en) (S)-9-(2,3-dihydroxy-1-propoxymethyl) guanine and its acyl derivatives, their preparation and their application as antiherpetic agents
EP0458312B1 (en) Novel cyclobutane derivatives
US5250688A (en) Purine derivatives
PT93852B (pt) Processo para a preparacao de purinil e pirimidinil-tetra-hidrofuranos com accao antiviral
JPH013185A (ja) 活性化合物、その製法及びそれを含む医薬組成物
US4880820A (en) Guanine derivatives
JP2962494B2 (ja) 新規なシクロブタン誘導体
WO1993006112A1 (en) Therapeutic nucleosides